NCT03788460

Brief Summary

The purpose of our study: Given the large number of coagulability tests done before a number of surgeries, specially otolaryngology procedures, such as tonsillectomy and adenoidectomy, as well as a part of epistaxis workup, prothrombin time (PT) and partial thromboplastin time (PTT) were checked, and it was found that in some people there is an isolated elongated PT, a low level of factor VII was found in these people. The purpose of the current study is to find a correlation between the value of PT\\INR and the level of factor VII, we tried to do so by a retro-prospective study on patients known to have a factor VII deficiency at Laniado hospital, such a correlation could make both the diagnosis and the management of people with factor VII deficiency easier and more accessible. The study levels:

  1. 1.Data collection : On the children's population who are known for their lack of Factor VII, we will check PT levels, we will concentrate the data in the table, along with personal information such as age and gender
  2. 2.Data Processing : We will try to conduct a statistical relationship between the PT values and Factor VII levels, to look for statistical significance, we will try to find a model for predicting the level of factor VII based on PT
  3. 3.A participant who is 0-18 years old
  4. 4.A participant who is, except for bleeding tendency, healthy in general
  5. 5.A participant who has elongated PT
  6. 6.A participant who has normal PTT
  7. 7.Background disease
  8. 8.Use of medications
  9. 9.Use of anti coagulation drugs

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2019

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 11, 2018

Completed
16 days until next milestone

First Posted

Study publicly available on registry

December 27, 2018

Completed
11 days until next milestone

Study Start

First participant enrolled

January 7, 2019

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2020

Completed
Last Updated

December 27, 2018

Status Verified

December 1, 2018

Enrollment Period

12 months

First QC Date

December 11, 2018

Last Update Submit

December 25, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Correlation between PT, INR and the level of coagulant factor VII

    correlation between PT / INR value and percent of factor VII through a retro-prospective study of patients who are known to have factor VII deficiency. This correlation is expected to facilitate diagnostic and monitoring procedures for patients with factor VII deficiency. The clinical value of this study is to facilitate diagnosis and treatment in patients with Factor VII defiency.

    Study completion within 2 years

Study Arms (1)

childrens population with lack of Factor VI

We will check PT levels, we will concentrate the data in the table, along with personal information such as age and gender. We will try to conduct a statistical relationship between the PT values and Factor VII levels, to look for statistical significance, we will try to find a model for predicting the level of factor VII based on PT

Other: no intervention

Interventions

no intervention

childrens population with lack of Factor VI

Eligibility Criteria

AgeUp to 18 Years
Sexall
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Children with known factor VII deficiency

You may qualify if:

  • Elongated PT value; Normal PTT value;

You may not qualify if:

  • Background medical conditions; Taking anticoagulants; Taking chronic medications;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Epistaxis

Condition Hierarchy (Ancestors)

Nose DiseasesRespiratory Tract DiseasesOtorhinolaryngologic DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and SymptomsSigns and Symptoms, RespiratorySigns and Symptoms

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head, Pediatric hemato-oncology unit

Study Record Dates

First Submitted

December 11, 2018

First Posted

December 27, 2018

Study Start

January 7, 2019

Primary Completion

January 1, 2020

Study Completion

January 1, 2020

Last Updated

December 27, 2018

Record last verified: 2018-12

Data Sharing

IPD Sharing
Will not share